We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Gsh4.8
Glutathione Research
Mostly mechanism / observational
17 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Glutathione studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2011–2026 with a typical study size of 194 participants.
Based on 17 studies · 2 meta-analyses · 10 RCTs · 1,267 total participants
Confidence
High
By outcome
Therapeutic & clinical
Mostly mechanism / observational3 studies
Skin tone & pigmentationPopular oral skin-lightening use; systematic-review evidence is mixed and modest · 8-12 weeks
Mostly mechanism / observational3 studies
Skin healthModest, often temporary skin-lightening / more even tone · 4-12 weeks
Too few graded studies2 studies
Depression & mood
Too few graded studies1 study
Glucose & metabolic
Too few graded studies1 study
Safety profile
Too few graded studies1 study
Weight management
Too few graded studies1 study
Active research area
11 studies in the last 5 years · Latest meta-analysis: 2026
201120182026
1Glutathione-related enzyme activities in depressionMeta-Analysisn=1,019 · large study2026
Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.
Etani T et al. · Neuropsychopharmacology reports (2026)
Our meta-analysis indicated significantly decreased activity of GPx in patients with depression compared with HC, while the levels of GSH and GR were not significantly different between the groups.
Because no studies, or an insufficient number of studies, have been conducted on GSSG, GST, GCL, and GS, meta-analyses were not performed for these metabolites and enzyme activities.
Our findings suggest that abnormal cycling of the GSH system, particularly decreased GPx activity, is involved in the pathophysiology of depression and may serve as a potential biomarker for this illness.
Such supplementation can be beneficial, and it is most effective when combined with a diet rich in sulfur-containing foods and other nutrients that support GSH synthesis.
Bradauskienė V et al. · Nutrients (2026)
Whether through diet or supplementation, ensuring adequate GSH levels can have profound benefits on longevity, immunity, and overall well-being.
There are many foods known to contain GSH, and there are also many GSH supplements available on the market, but precursor-based supplements and compounds that activate GSH synthesis pathways show stronger and more consistent increases in human GSH.
A diet rich in protein (for amino acids) and phytochemical-dense plants can support this, while targeted precursors (e.g., glycine, γ-glutamylcysteine) and Nrf2-activating foods or agents provide the most robust increases shown so far.
To elucidate the clinical significance of glutathione, future research should focus on conducting randomized controlled trials, developing standardized formulations, and performing long-term safety assessments.
Stanescu C, Chiscop I, Boev M, Stanescu GD, Matei MN. · Molecules (Basel, Switzerland) (2026)
A consistent correlation exists between reduced GSH levels and neuronal dysfunction.
Elevated GSH levels enhance cellular resistance to oxidative stress and reduce apoptotic signaling.
GSH plays a pivotal role in cutaneous aging and tissue repair through redox regulation, mitochondrial protection, and the modulation of inflammatory and extracellular matrix pathways.
However, due to the limited number of studies, further investigations is suggested in this regard.
Musazadeh V, Mahmoudinezhad M, Hamidi N, Falahatzadeh M, Shidfar F. · Prostaglandins & other lipid mediators (2025)
Data were subjected to meta-analysis using a random effects model to examine the effect sizes of the pooled results.
Walnut consumption resulted in a significant increase in catalase activity (CAT) (WMD: 42.20; 95 % CI: 34.28, 50.11).
Walnut consumption did not affect other biomarkers of oxidative stress such as lipid peroxidation (LPO), reduced glutathione (GSH), oxidized glutathione (GSSG) and oxygen radical absorbance capacity (ORAC).